Bank of New York Mellon Corp - ONCTERNAL THERAPEUTICS INC ownership

ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 27 filers reported holding ONCTERNAL THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ONCTERNAL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,280
-13.0%
17,6000.0%0.00%
Q2 2023$6,072
-56.1%
17,6000.0%0.00%
Q1 2023$13,816
-21.5%
17,6000.0%0.00%
Q4 2022$17,600
+10.0%
17,6000.0%0.00%
Q3 2022$16,000
-20.0%
17,6000.0%0.00%
Q2 2022$20,000
-89.5%
17,600
-87.1%
0.00%
Q1 2022$190,000
-40.3%
136,428
-2.6%
0.00%
Q4 2021$318,000
-44.7%
140,057
+1.7%
0.00%
Q3 2021$575,000
-5.4%
137,781
+7.6%
0.00%
Q2 2021$608,000
+316.4%
128,058
+627.6%
0.00%
Q1 2021$146,000
+53.7%
17,600
-9.3%
0.00%
Q4 2020$95,000
-15.9%
19,406
+14.0%
0.00%
Q2 2019$113,00017,0250.00%
Other shareholders
ONCTERNAL THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 360,000$1,501,0000.78%
Parkman Healthcare Partners LLC 325,384$1,357,0000.34%
Vigilare Wealth Management 63,460$265,0000.16%
BRIGHTON JONES LLC 333,875$1,392,0000.07%
HighVista Strategies LLC 23,121$97,0000.06%
Ikarian Capital, LLC 199,180$830,0000.06%
Total Clarity Wealth Management, Inc. 26,430$110,0000.05%
IPG Investment Advisors LLC 30,756$128,253,0000.04%
DOWLING & YAHNKE LLC 150,464$627,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 22,015$92,0000.01%
View complete list of ONCTERNAL THERAPEUTICS INC shareholders